STOCK TITAN

AbbVie to Host Full-Year and Fourth-Quarter 2023 Earnings Conference Call

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
AbbVie (NYSE: ABBV) to announce full-year and fourth-quarter 2023 financial results on February 2, 2024, before market opens. Live webcast of earnings conference call at 8 a.m. CT accessible through AbbVie's Investor Relations website at investors.abbvie.com.
Positive
  • None.
Negative
  • None.

NORTH CHICAGO, Ill., Jan. 4, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its full-year and fourth-quarter 2023 financial results on Friday, February 2, 2024, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT. It will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.

 

Cision View original content:https://www.prnewswire.com/news-releases/abbvie-to-host-full-year-and-fourth-quarter-2023-earnings-conference-call-302019267.html

SOURCE AbbVie

FAQ

When will AbbVie announce its full-year and fourth-quarter 2023 financial results?

AbbVie will announce its full-year and fourth-quarter 2023 financial results on February 2, 2024, before the market opens.

What is the ticker symbol for AbbVie?

The ticker symbol for AbbVie is ABBV.

Where can I access the live webcast of AbbVie's earnings conference call?

The live webcast of the earnings conference call will be accessible through AbbVie's Investor Relations website at investors.abbvie.com.

What time will the earnings conference call be held?

The earnings conference call will be held at 8 a.m. CT.

Where can I find the archived edition of the earnings conference call session?

An archived edition of the session will be available later on the same day on AbbVie's Investor Relations website.

ABBVIE INC.

NYSE:ABBV

ABBV Rankings

ABBV Latest News

ABBV Stock Data

290.01B
1.76B
0.11%
71.92%
0.74%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
NORTH CHICAGO

About ABBV

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohns disease, plaque psoriasis, and ulcerative colitis.